, Tracking Stock Market Picks
Enter Symbol:
Horizon Pharma Inc (HZNP) [hlAlert]

up 843.69 %

Horizon Pharma Inc (HZNP) rated Buy with price target $13 by R. F. Lafferty

Posted on: Wednesday,  Feb 19, 2014  11:25 AM ET by R. F. Lafferty

R. F. Lafferty rated Buy Horizon Pharma Inc (NASDAQ: HZNP) on 02/19/2014. Previously R. F. Lafferty rated Buy Horizon Pharma Inc (NASDAQ: HZNP)
on 10/03/2013., when the stock price was $3.25. Since then, Horizon Pharma Inc has gained 843.69% as of 01/19/2016's recent price of $30.67.
If you would have followed the previous R. F. Lafferty's recommendation on HZNP, you would have gained 843.69% of your investment in 838 days.

Horizon Pharma, Inc. (Horizon) is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company?s other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company?s distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation.

R. F. Lafferty
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/19/2014 11:25 AM Buy
11.02 13.00
as of 10/17/2014
1 Week down  -2.50 %
1 Month down  -5.04 %
3 Months down  -14.94 %
1 YTD up  53.14 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2014 4:25 PM Buy
10.47 11.00
10/3/2013 10:25 AM Buy
3.25 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy